Bristol Myers multiple myeloma drug improves survival by 50% in late-stage study
Bristol-Myers Squibb Co. · PHARMACEUTICAL PREPARATIONS · Now $57.18
+0.1% in 1h after detection
Post-detection moves
1h
+0.1%
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS